REGISTERED
on 07 May 2024
Last Applicant/ Owned by
Paasheuvelweg 25
Amsterdam
NL
1105BP
Serial Number
90736220 filed on 26th May 2021
Registration Number
7376828 registered on 07th May 2024
Correspondent Address
Julianne Abelman Womble Bond Dickinson (US) LLP
Filing Basis
1. intent to use
Disclaimer
NO DATA
LINQURE
Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics, namely, pharmaceutics in the field of gene therapy Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics, namely, pharmaceutics in the field of gene therapy
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics, namely, pharmaceutics in the field of gene therapy
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Medicinal preparations for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases, namely, viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors; Viral systems, gene therapy systems, nucleic acid delivery systems for medical purposes, namely, medicines for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; clinical medical reagents for use in nucleic acid based therapy, gene therapy, cell therapy, gene diagnosis and gene testing
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 90736220
Mark Type
No Service Mark
Attorney Docket Number
No 880685
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 07th May 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 07th May 2024 | REGISTERED-PRINCIPAL REGISTER |
| 27th Jan 2023 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| 26th Jan 2023 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| 25th Jan 2023 | ASSIGNED TO PETITION STAFF |
| 12th Jan 2023 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| 18th Aug 2022 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| 20th Jul 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 20th Jul 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 20th Jul 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |